Missionpharma, officially known as Missionpharma A/S, is a leading provider of healthcare solutions headquartered in Denmark (DK). Established in 2000, the company has made significant strides in the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical devices across various regions, including Africa and Asia. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including generic pharmaceuticals, surgical instruments, and diagnostic tools. Their unique approach combines quality assurance with competitive pricing, ensuring that healthcare providers receive reliable products tailored to their needs. Recognised for their dedication to social responsibility, Missionpharma has positioned itself as a trusted partner in global health initiatives, contributing to improved health outcomes in underserved communities.
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Missionpharma's score of 31 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Missionpharma reported carbon emissions of approximately 273,000 kg CO2e, with all emissions classified under Scope 1. This marks an increase from 250,000 kg CO2e in 2022 and 162,000 kg CO2e in 2021. The company has not disclosed any Scope 2 or Scope 3 emissions, indicating a focus solely on direct emissions from owned or controlled sources. Despite the rising emissions, Missionpharma has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction strategies or climate pledges. This lack of formal commitments may reflect broader industry challenges in addressing carbon footprints effectively. As a company headquartered in Denmark (DK), Missionpharma's emissions data highlights the need for enhanced climate action and transparency in their sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | 162,000 | 000,000 | 000,000 | 000,000 |
Scope 2 | - | - | - | - |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Missionpharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.